Efficacy of morantel against nematode populations in calves exposed on a pasture stocked for two years with morantel sustained-release bolus-treated calves

Two groups of 10 parasite-free calves were maintained either for 2 weeks on a pasture grazed by nonmedicated cattle (pasture A) or for 3 weeks on a pasture grazed by morantel sustained-release bolus-treated cattle (pasture B) for the preceding 2 years. After a 4-week holding period to allow for maturation of acquired gastrointestinal nematodes, 5 calves from each group were administered a therapeutic dose (10 mg/kg of body weight) of morantel tartrate. All calves were necropsied 1 week later, and the abomasal and small intestinal nematodes were isolated, identified, and enumerated. A comparison of efficacies between nonmedicated and morantel tartrate-treated calves of each pasture demonstrated that morantel was equally effective against the gastrointestinal nematode infections, regardless of infection source (ie, pasture A vs pasture B). The overall nematode reductions due to morantel tartrate treatment of calves that grazed pastures A and B were 98% and 96%, respectively. It was concluded that the sensitivity of gastrointestinal nematodes to morantel tartrate was not diminished in calves maintained on pasture B, which had been stocked with morantel sustained-release bolus-treated calves for the preceding 2 grazing seasons.     

Efficacy of a morantel sustained-release bolus for the control of gastrointestinal nematodes in Florida dairy heifers

The effectiveness of a morantel sustained-release bolus (MSRB) in controlling gastrointestinal nematode infections was determined in 70 Holstein heifer calves with no prior grazing experience. Calves were allotted to 2 treatment groups and were maintained in Florida during the grazing season on divided pastures of equal area. One MSRB was administered to each calf in 1 group at the time of turnout onto spring pasture, whereas calves in the other group remained as nonmedicated controls. By the end of the grazing season, treatment resulted in significantly (P less than 0.05) lower worm burdens and significantly improved weight gains. The MSRB-treated calves were able to reach breeding weight 2 to 4 weeks earlier than did nonmedicated calves.     

A morantel sustained-release bolus for the control of gastro-intestinal nematodes in grazing calves

Prophylactic (summer) and/or therapeutic (autumn) administrations of an intra-ruminal sustained-release bolus (MSRB) containing morantel tartrate were compared for the control of gastro-intestinal nematodes in grazing dairy calves over an 8-month period (December to August). The MSRB was designed to release morantel tartrate at 150 mg/day for 90 days.

Treated and untreated groups of calves grazed separate replicated pastures. Both groups of calves receiving the MSRB at the beginning of summer showed a significant mean liveweight advantage (17.7 kg and 20.7 kg for the summer and summer/autumn treated groups, respectively) at the end of the trial period, when compared with untreated calves. The liveweight advantage of calves receiving the MSRB in autumn only (6.5 kg) was not significantly different from that of the controls.

Both the summer and autumn administrations of the MSRB prevented the accumulation of Pre-Type II burdens of Ostertagia spp.

Retention rates of the MSRB were high and chemical analysis of faecal samples indicated a fairly constant release of the anthelmintic over the predicted 90-day period.

The results indicate that the MSRB is potentially useful for the control of gastro-intestinal nematodes, and particularly for the production of ’safe’ pasture. The MSRB could provide an effective alternative to integrated control based primarily on grazing management.     

A comparison of the morantel sustained-release bolus with conventional drenching for the control of gastro-intestinal nematodes in grazing calves

A comparison was made of the parasitological and production responses to the prophylactic (summer) and combined prophylactic and therapeutic (summer/autumn) administrations of the morantel intraruminal, sustained-release bolus (MSRB) with responses to conventional drenching in grazing dairy calves over an 8-month period. The MSRB was designed to release morantel tartrate at 150 mg/day for 90 days. In two concurrent trials, groups of calves grazed separate replicated pastures. In Trial 1, the combined summer (December) and autumn (March) administration of the MSRB was compared with a programme of six drenches (oxfendazole at 4.53 mg/kg) at 28-day intervals from December to May. In Trial 2, the summer administration of the MSRB was compared with a programme of three autumn drenches (oxfendazole) at 28-day intervals from March to May. There were no significant between-treatment differences in mean liveweight gain in either trial. In both trials, the low numbers of eggs passed by the MSRB-treated animals during summer (maximum mean 62 eggs per gram of faeces) were sufficiently high to produce a modest autumn larval peak (maximum 1990 larvae/kg herbage). In Trial 2, the summer use of the MSRB resulted in an 83% reduction in peak larval availability compared with that on pastures grazed by untreated calves during summer. Only the 6-drench regimen (Trial 1) prevented the accumulation of appreciable worm burdens of early 4th stage Ostertagia spp.     

Efficacy of the morantel sustained release trilaminate bolus against gastrointestinal nematodes and its influence on immunity in calves.

An experiment was conducted in calves to investigate the efficacy of a morantel sustained release trilaminate bolus (MSRT) to control gastrointestinal parasitism and to assess the development of immunity during the use of MSRT. Two groups (M and U) of four calves each were infected three times a week with a mixed Ostertagia ostertagi and Cooperia oncophora infection for 12 weeks. Calves of Group M received an MSRT at the start of the experiment. Twenty weeks after the start of the experiment, all animals, including a previously uninfected control group (C), received a challenge with 100,000 Ostertagia and 100,000 Cooperia. After a further 4 weeks all calves were necropsied for worm counts. During the trial calves were weighed and faecal egg counts, larval differentiation and pepsinogen concentrations were determined. The results demonstrated the high level of efficacy of the MSRT in reducing the faecal egg output and preventing parasitic gastroenteritis under conditions of a continuous high rate of infection. Efficacy of treatment was higher for Cooperia than for Ostertagia. Post-mortem worm counts suggested a partially impaired immunity build-up in Group M, at least for Cooperia.     

Autumn acquisition of nematodes by calves given a morantel sustained-release bolus the preceding spring

Reinfection with nematodes late in the grazing season was assessed in calves treated the preceding spring with a morantel sustained-release bolus (MSRB). During an initial 155-day grazing period, MSRB-treated calves (n = 15) grazed a pasture used the preceding year for identically treated calves (MSRB pasture). Control calves (n = 15) were not given anthelmintic treatment in the spring and grazed heavily contaminated herbage for the initial 155-day period (control pasture). At the end of the initial grazing period, 3 calves from each group were killed for parasite recovery and counting, with control calves found to harbor 9.2 times more nematodes, compared with the MSRB-treated calves. Nematode counts from tracers killed periodically during the initial grazing period were of similar proportions, reflecting the much greater nematode exposure experienced by the control calves, compared with the MSRB-treated calves. At the end of the initial grazing period, 10 calves (5/group) were placed on a common, contaminated pasture after all were treated twice with fenbendazole (10 mg/kg of body weight, 7 days apart) while on concrete. The second grazing period was for 29 days, followed by a 3-day confinement on concrete. Then, the calves were killed and necropsied. During the 29-day grazing period, the MSRB-treated calves maintained their weight advantage over the control calves, and significant differences in nematode egg counts were not found between the 2 groups of calves. At necropsy, the MSRB-treated calves harbored 27.9% fewer nematodes than did the controls, indicating that prior therapeutic and prophylactic anthelmintic activities of the MSRB did not predispose the animals to enhanced acquisition of nematodes after MSRB protection.     

Grazing study in Ireland using the morantel sustained release bolus for controlling nematodiasis in calves

The morantel sustained release bolus was administered at turnout to first-season grazing calves in order to assess its efficacy in the seasonal control of infection by nematode parasites in Ireland. The pastures grazed by control calves showed a marked increase in gastrointestinal trichostrongylid infective larvae by September, while numbers of infective larvae on pasture grazed by bolus-treated calves remained at a low level throughout the grazing season. In consequence, the controls showed significantly higher worm egg counts in late season and significantly higher worm burdens (mainly Ostertagia spp) at necropsy carried out in November on representative number of principal animals selected from each group. These reduced worm burdens were attributed to the suppression of egg output during the early part of the season as a result of treatment with the morantel sustained release bolus at turnout in the spring. Pasture contamination with Dictyocaulus viviparus larvae was present on all treatment pastures. The bolus-treated calves however were subjected to an increase in D. viviparus infection which occurred on their pasture in late season after the active life of the bolus had expired. It was concluded that bolus treatment delayed (rather than prevented) the buildup of D. viviparus infection on the pasture by 60-90 days.     

Pharmacodynamics, pharmacokinetics and faecal persistence of morantel in cattle and goats

Morantel could not be detected (<0.05 pg/ml)in the plasma of cattle or goats followingthe oral administration of morantel tartrate at a dose rate of 10 mg/kg
bodyweight. No morantel was detected in the milk of lactating goats except in
one animal where a concentration of 0.092 pg/ml was detected at 8 h after drug
administration. Morantel was highly effective against Cooperia oncophora infec-
tions in calves treated 6, 9 or 18 days after infection; however, was highly
effective against Ostertagia ostertagi only when treated 18 days after infection.
Morantel did not affect the fecundity of adult 0.ostertagi surviving treatment 18
days after infection which had similar average numbers of eggs in their uteri
(range 13.4 f 0.73-16.8 L 0.98) as did parasites from control animals (range
12.0 k 0.70-13.6 2 0.66). Morantel could be detected at a concentration of 96 k
4.5 pgig (dry weight) in the faeces of a calf 24 h after treatment with I0 mgikg
bodyweight of morantel tartrate. The concentration of morantel in replicate
samples of this faeces exposed to natural atmosphere, but not to soil or soil
organisms, declined slowly over the following 322 days. At day 322 after the start
of the experiment 8.8 pg/g of morantel could be measured in the remaining
faecal material. Throughout the faecal degradation study the concentration of
morantel in the crusts of the replicate sample pats was lower than the
concentration in the core samples.     

Efficacy of morantel sustained release bolus against gastrointestinal nematodes in first season grazing Holstein calves

The efficacy of the morantel sustained release bolus (MSRB) in reducing gastrointestinal parasitism in first season grazing calves was evaluated during the summer--autumn grazing seasons of 1982 and 1983 in western Oregon. Each of 38 calves (1982) and 40 calves (1983) were randomly assigned to either control or treatment groups which were given MSRB on the day of turnout onto pasture. Mean worm burdens from tracer calves grazed with treated animals in 1982 and 1983 showed overall reductions of 86.4% (P greater than 0.05) and 84.3% (P less than 0.01), respectively, compared to tracers grazed with controls. Ostertagia ostertagi, Cooperia oncophora and Nematodirus helvetianus were the primary nematodes collected at necropsy. Twelve full-season 1982 tracer animals (6 treated and 6 control) indicated an 88.1% (P less than 0.05) overall reduction in mean worm burdens. Mean fecal worm egg per gram (EPG) counts of treated animals reflected a reduction of 69% (P less than 0.05) in 1982 and 90% (P less than 0.05) in 1983. Autumn inhibition of O. ostertagi was observed. In the 1982 trial the control animals showed a slight mean weight gain advantage over the treated group from Day 84 until Day 160 (trial termination) when the mean difference was 7.9 kg. The final mean weight gain advantage of treated animals in 1983 was 13.5 kg (P less than 0.05). These trials demonstrated that the MSRB was an effective anthelmintic for reducing gastrointestinal parasitism in grazing calves and for decreasing pasture larval contamination.     

Efficacy of morantel sustained-release bolus in control of gastrointestinal nematodes of weaned calves during the autumn-winter grazing season

A 168-day study was conducted to evaluate the efficacy of morantel tartrate sustained-release bolus (MSRB) in controlling gastrointestinal parasitism in weaned calves during autumn-winter grazing in the temperature climate of southern United States. Sixty-two weanling Angus heifers were used to assess treatment differences. Six sentinel heifers were necropsied to assess pretrial gastrointestinal worm counts. The remaining 56 heifers were assigned to 4 groups of 14 heifers each and were placed on four 4.86-hectare dormant Bermuda grass pastures (1 group/pasture) that had been no-till interseeded with cereal rye in early October. Heifers in 2 groups were given 1 MSRB in early November; the other 2 groups served as nonmedicated controls. Three heifers (principals) from each of the 4 groups were necropsied on posttreatment days 57, 112, and 168 (end of study) for total worm recovery. Eight 5-month-old tracer steers, raised worm-free from birth, grazed the 4 pastures (2/pastures) for the first 21 days of the study and then were kept in drylot for 21 days before being necropsied. Level of larval contamination of pastures grazed by control and MSRB-treated heifers were comparable, because the mean number of nematodes recovered from tracer steers grazing the control and MSRB pastures were 47,449 and 53,835, respectively. At 28 days after treatment, MSRB-treated heifers had lower (P less than 0.05) mean egg counts/g of feces than did control heifers (280 vs 13).(ABSTRACT TRUNCATED AT 250 WORDS)     

Evaluation of the morantel sustained release bolus in cows and calves

The efficacy of the morantel sustained release bolus (MSRB) in controlling gastrointestinal parasitism in beef cattle was assessed during the 1982 spring-autumn grazing season. Forty-eight cows and their calves were allotted to three equal groups. One group (T-1) served as a nonmedicated control group. One MSRB was administered to each calf of the T-2 group, and to each cow and calf of the T-3 group at the beginning of the study. The efficacy of the bolus was assessed by comparison of weight gain performance and parasitological data (fecal worm egg counts, herbage larval counts, worm counts from tracer and principal trial calves, and plasma pepsinogen level determinations). Though not statistically significant, treated calves from Group T-2 had a numerical mean weight gain advantage of 2.6 kg, and those from Group T-3 of 4.7 kg, over control calves. Average daily gains (ADG) for the three groups of calves were 0.69, 0.72, and 0.73 kg, respectively. Untreated cows from Group T-2 and treated cows from Group T-3 outperformed the control cows by 12.3 and 7.5 kg, respectively. Fecal worm egg counts from both groups of treated calves were significantly (P less than 0.01) lower than counts from control calves during the entire 169-day trial; notably, egg counts were reduced by 99% 28 days after MSRB administration to both groups of calves. There were no significant differences in the number of eggs counted from the three groups of cows, probably because of the very low numbers of eggs encountered. Mean total worm burdens of principal calves (six per group) necropsied at trial termination indicated a 91% (P less than 0.01) reduction in Group T-2 and an 87% reduction (P less than 0.01) in Group T-3. Worm-free tracer calves were introduced onto pastures every 28 days to monitor availability of infective larvae. The mean number of worms recovered at necropsy from tracer calves that grazed with control cattle increased as the season progressed. However, the numbers of parasites recovered each month from mid-August through mid-October from tracers that grazed pastures with treated cattle were lower (P less than 0.05) than those levels displayed at trial initiation. In addition, the mean numbers of worms from treated group tracers were lower than from the controls for each necropsy period.(ABSTRACT TRUNCATED AT 400 WORDS)     

Efficacy of a morantel sustained-release bolus for control of gastrointestinal parasites in winter-grazed steers in Mississippi

From Nov 22, 1983 through May 15, 1984, 36 crossbred steers were allotted into 3 treatment groups (12/group) and were grazed on separate 3.4-hectare pastures. On Nov 22, 1983, the steers were administered a single morantel sustained-release bolus (MSRB), orally (group 1), or a single dose of thiabendazole (TBZ; 66 mg/kg of body weight, orally; group 2), or were left untreated (group 3; controls). Animal weights, nematode egg counts in fecal specimens, and plasma pepsinogen concentrations were monitored monthly. At the termination of the study, 4 steers from each treatment group were slaughtered and necropsied and worm counts were determined. A set of parasite-free tracer calves (3/treatment group) were grazed with each treatment group for 1 month, beginning on Nov 22, 1983; a second set of tracer calves (3/group) were grazed with each treatment group for 1 month, beginning Apr 3, 1984. At the end of their respective grazing periods, tracer calves were held for 3 weeks and then were slaughtered and necropsied and their worm counts were determined. Mean nematode egg counts in fecal specimens of group 1 (MSRB treated) were significantly lower (P less than 0.05) than that of the TBZ-treated or nontreated steers. Differences in worm counts were not found between treatment groups. Differences in worm counts of tracer calves were not found among the 3 groups for November 1983 nor for April 1984. Steers treated with the MSRB had a higher mean weight gain (P less than 0.06) than did the control or TBZ-treated steers.     

Therapeutic and prophylactic efficacy of morantel when administered directly into the rumen of cattle on a continuous basis

The efficacy of morantel tartrate when administered on a continuous basis directly into the rumen/reticulum of cattle, either by a cannula or from a specially designed device, was evaluated against gastrointestinal parasites under laboratory conditions. In two experiments the continuous infusion of morantel at rates between 0.26 and 1.04 mg/kg body weight per day using a peristaltic pump was highly efficacious in both preventing the establishment of infections and removing established infections of the following species: Ostertagia ostertagi, Haemonchus contortus, Cooperia oncophora and Trichostrongylus colubriformis. The same dose rates also prevented establishment of Dictyocaulus viviparus infection but were ineffective against established infections of this parasite. In another two experiments the continuous release of morantel tartrate for at least 60 days (at rates between 0.65 and 1.11 mg/kg body weight per day) from a specially designed intraruminal sustained release bolus (secured at each end by a polyethylene impregnated semi-permeable membrane) was highly efficacious in both preventing the establishment of infections and removing established infections of the following species: O. ostertagi, T. axei, T. colubriformis and C. oncophora.     

Prophylactic efficacy of an ivermectin sustained-release bolus against challenge exposure with gastrointestinal and pulmonary nematode infective larvae in calves

Twelve Holstein calves were used to determine the prophylactic efficacy of ivermectin against challenge exposure with gastrointestinal and pulmonary nematodes. Two groups of 6 calves (mean body weight, 205 kg) each were formed by restricted randomization according to body weight. Group-1 calves served as nonmedicated controls. Each calf of group 2 was orally given one prototype sustained-release bolus designed to deliver ivermectin at a continuous daily dose of 8 mg. Third-stage nematode infective larvae were given to the calves on posttreatment days 28 and 42. The calves were euthanatized 77 or 78 days after treatment. Ivermectin was 100% effective (P less than 0.05) in preventing the establishment of infection by Haemonchus placei, Ostertagia ostertagi, Cooperia spp (C punctata, C oncophora, C surnabada), Nematodirus helvetianus, Oesophagostomum radiatum, and Dictyocaulus viviparus and was greater than 99% effective against Trichostrongylus axei. Incidental infection by Trichuris spp was reduced by 94% (P = 0.08).     

Seasonal prevalence of gastrointestinal nematodes of beef calves grazed on irrigated pastures in the lower Sacramento Valley of California

Two worm-free calves were allowed to graze on irrigated pasture with a naturally infected herd for each of 34 one-month periods from November 1979 to August 1982. After each grazing period, the calves were transferred to a cement-floored pen for 3 weeks and then were euthanatized and necropsied. Ostertagia ostertagi and Cooperia oncophora were the most prevalent species of nematodes recovered. Adults and larvae of Ostertagia spp and Cooperia spp were most numerous in winter and spring and least numerous during summer. The proportions of Ostertagia spp that were inhibited as fourth-stage larvae increased in late fall, peaked from March through April, and then decreased to low values during summer. The maximal inhibition in 1980, 1981, and 1982 was 72, 65, and 62%, respectively. The number of larval Cooperia spp was highest in winter months and, except for one grazing period when 55% of the Cooperia spp were larvae, the total numbers represented less than 15% of the nematode population during all grazing periods. Other nematodes encountered were Trichostrongylus axei, Haemonchus spp, O lyrata, and O occidentalis in the abomasum; C surnabata, C punctata, Nematodirus helvetianus, T colubriformis, and Bunostomum phlebotomum in the small intestine; and Oesophagostomum venulosum and Trichuris ovis in the large intestine.     

Efficacy of the morantel sustained release trilaminate matrix against gastrointestinal nematodes in beef calves

The effectiveness of the morantel sustained release trilaminate (MSRT) in controlling gastrointestinal nematodes through a grazing season was evaluated using 60 yearling beef stocker calves randomly divided into 2 groups of 30 animals each. In April 1985, the calves comprising the treatment group each received an MSRT designed to release morantel tartrate continuously for 90 days while those of the control group remained unmedicated. All animals were weighed and samples of rectal feces were taken at 14-day intervals, beginning on Day 0, until trial termination (Day 168). At trial termination, 10 control and 10 treated calves were necropsied for recovery of gastrointestinal nematodes. Three sets of parasite-na?ve tracer calves were utilized to evaluate the initial, interim and final levels of pasture contamination by nematode larvae. Overall, the use of the MSRT resulted in a 75.5% reduction (P less than 0.001) in output of nematode eggs from the principals, an 81.8% reduction (P less than 0.001) in numbers of gastrointestinal nematodes in principals (at trial termination), and a 96.9% reduction (P less than 0.05) of pasture larval nematode contamination (as indirectly indicated by parasite burdens in tracer calves). The mean weight advantage of treated calves was 16.6 kg per head (P less than 0.001).     

Efficacy of moxidectin against naturally acquired nematode infections in cattle.

The efficacy of moxidectin, a new endectocide against natural nematode infections, was evaluated. Twenty-five calves were divided into two groups of eight calves each and a third group of nine calves. Moxidectin was administered s.c. to two groups (I, 0.2 mg kg-1 body weight (BW); II, 0.3 mg kg-1 BW) and the third group (III) received the vehicle (placebo) s.c. Two pre-treatment and one post-treatment faecal nematode egg count determinations were made from all calves, and they were necropsied 2 weeks after treatment for the identification and enumeration of nematode parasites. Group III calves, which received the drug-free vehicle, harboured eight species of nematodes (Ostertagia ostertagi, Trichostrongylus axei, Cooperia oncophora, Cooperia punctata, Nematodirus helvetianus, Trichuris discolor, Oesophagostomum radiatum and Dictyocaulus viviparus). The mean total worm burden for this group was 8935. There was a significant reduction in the numbers of many species of nematodes (Ostertagia, Trichostrongylus, Cooperia and Nematodirus) in both treated groups. Cooperia oncophora was reduced by 94% in Group I and by 96% in Group II, while all other nematode species were reduced by 99%. Immature stages of Ostertagia and Nematodirus were significantly reduced in the two treated groups. Two weeks after treatment, the mean faecal egg counts of both treated groups were reduced by more than 98%. There was no significant difference in mean total worm burdens or egg counts between the two treated groups.     

Relationship between cytologic changes in bronchoalveolar lavage fluid and weight gain in calves with gastrointestinal nematodes and lungworms

Two of three groups of 10 calves each were infected with either 100,000 infective larvae (L3) of Ostertagia spp. and 100,000 L3 of Cooperia spp. or with 4000 L3 of Dictyocaulus viviparus, respectively, at the age of 14 weeks. The third group was not infected. After treatment with an anthelminthic five calves from each group were challenged with either 100,000 L3 of Ostertagia spp. and 100,000 L3 of Cooperia spp. or 4000 L3 of Dictyocaulus at the age of 20 weeks. The calves were 25 weeks old when slaughtered. Total and differential cell counts were determined in bronchoalveolar lavage fluid and showed that neutrophils were the most frequent and eosinophils the least frequent cell present. There was a significant negative relationship between eosinophil levels and weight gain of the calves.     

Efficacy of oxfendazole against inhibited larvae of Ostertagia ostertagi acquired by calves in the spring

During the spring of 1985, 40 calves grazed pastures known to have high numbers of spring inhibition-prone, infective Ostertagia ostertagi larvae. Calves were removed from pasture and placed in outdoor pens with concrete floors from 10 days prior to treatment until necropsy 14 days after treatment. Ten calves were allocated to each of 4 treatment groups, and oxfendazole was administered to each group by intraruminal injection at dosages of 0, 2.25, 4.5, and 6.75 mg/kg of body weight. Efficacies greater than or equal to 94.6% were achieved at dosages of 4.5 and 6.75 mg/kg against adult Ostertagia spp, Trichostrongylus spp, Haemonchus placei, Cooperia punctata, Bunostomum phlebotomum, Oesophagostomum radiatum, and Dictyocaulus viviparus. Efficacy against inhibited larvae of O ostertagi was variable, with the highest efficacy (90.2%) attained at a dosage of 6.75 mg/kg.     

A new approach in the prevention of gastrointestinal parasitic infections in cattle

The efficacy of a morantel long-acting device in preventing parasitic gastroenteric infections throughout a whole year was evaluated in heifers and steer calves in south central Québec. Thirty-two calves, comprising nine Hereford steers, one Hereford heifer, fourteen Holstein crossbred steers and eight Holstein crossbred heifers, were allotted into two treatment groups and maintained throughout the grazing season on adjacent pastures resulting from equivalently dividing one original pasture. One morantel long-acting device was administered to each animal in one group at the time of turnout onto the pasture in the spring while the calves in the other group remained as nonmedicated controls. The parasitic infections incurred during the pasture season were primarily Ostertagia, Trichostrongylus, Cooperia and Nematodirus.

The following fall, after twelve calves were necropsied for worm counts, the twenty remaining ones were brought into the barn where they were kept throughout the winter with access to an outside yard. They received good quality hay and rolled barley (1 kg/head/day) up until the following May, at which time they were weighed and had fecal samples taken for egg counts. In contrast to the results observed among controls, the morantel long-acting device treatment group had an 87% reduction in fecal worm egg excretion and a 67.3 kg per calf increased weight gain after one year.